GlassScriptPhysician profile
Isma Nusrat Javed
NPI 1285087536
$15,420.77
in general payments reported to CMS, 2019-2025
32 companies · $799 in 2025
The $799 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $1,105 · 2021: $498 · 2022: $6,288 · 2023: $5,511 · 2024: $697 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,918 · Travel and Lodging: $2,730 · Education: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,918.19 |
| Travel and Lodging | $2,730.42 |
| Education | $358.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,964.50 | 2022-2025 | Impella |
| Abbott Laboratories | $2,843.03 | 2022-2025 | Supera, Ensite, Mitraclip |
| Boston Scientific Corporation | $1,619.86 | 2020-2025 | Cds Broad Portfolio Offering |
| Philips North America LLC | $1,306.26 | 2022 | |
| Edwards Lifesciences Corporation | $1,180.40 | 2021-2022 | |
| Inari Medical, INC. | $1,083.38 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merit Medical Systems INC | $636.73 | 2022 | |
| Medtronic Vascular, INC. | $494.82 | 2019 | |
| Medtronic, INC. | $357.44 | 2021-2023 | Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $261.32 | 2021-2025 | Lifevest |
| Cardiovascular Systems INC. | $165.45 | 2022-2023 | Diamondback Coronary |
| Actelion Pharmaceuticals US, INC. | $149.41 | 2022-2023 | Opsumit, Uptravi |
| Irhythm Technologies, INC. | $148.52 | 2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $139.10 | 2023 | Optimizer |
| Penumbra, INC. | $138.41 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $132.42 | 2023 | Turnpike, Guideliner |
| Alnylam Pharmaceuticals INC. | $122.62 | 2023-2024 | Onpattro |
| Asahi Intecc USA, INC. | $115.38 | 2022 | |
| Ge Healthcare | $100.21 | 2022 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $55.66 | 2025 | |
| Cathworks, INC. | $44.96 | 2022 | |
| Amgen INC. | $42.96 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $39.12 | 2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $38.81 | 2024-2025 | Nexletol |
| Shockwave Medical, INC | $34.74 | 2025 | |
| Kestra Medical Technology Services, INC. | $25.54 | 2023 | Assure Wcd |
| Terumo Medical Corporation | $24.32 | 2024 | Angio-Seal |
| Cardiva Medical, INC. | $24.23 | 2022 | |
| Pfizer INC. | $19.50 | 2025 | |
| Scpharmaceuticals INC. | $19.33 | 2025 | |
| Bard Peripheral Vascular, INC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isma Javed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.